INmune Bio: Q4 Earnings Insights

INmune Bio Inc. -7.00%

INmune Bio Inc.




INmune Bio (NASDAQ:INMB) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.


INmune Bio missed estimated earnings by -7.000000000000001%, reporting an EPS of $-0.47 versus an estimate of $-0.44.

Revenue was down $69 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.07 which was followed by a 4.0% drop in the share price the next day.

To track all earnings releases for INmune Bio visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via